Another established risk factor is immunosuppression, especially with chemotherapy and HIV
Ock S, Lee WS, Ahn J, Kim HM, Kang H, Kim HS, et al
All doses of tirzepatide and semaglutide were superior to placebo in achieving at least a 10% body weight reduction, with tirzepatide 15 mg (risk ratio = 10.51 [95% CI 7.55, 14.64]) and tirzepatide 10 mg (risk ratio = 8.84 [95% CI 6.35, 12.32]) being the most efficacious treatments (ESM Table 13)
Glutathione for Mycotoxins Series of treatments Intravenous Glutathione is our main treatment for the management of mycotoxins (mold toxins) excreted from the body in urine testing Glutathione is central to mycotoxin detoxification and is necessary for people with impairment in their glutathione detoxification capacity It is done in a series of increasing doses, twice weekly over the course of 4 weeks